Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Journal of Diabetes and Its Complications|December 12, 2018
PAX4 R192H is associated with younger onset of Type 2 diabetes in East Asians in SingaporeSu Fen Ang, Clara S H Tan, Ling Wang, et al.
Diabetologia|May 6, 2009
Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individualsS C Lim, J J Liu, H Q Low, et al.
Oncogene|June 11, 2008
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiationC Sun, A Dobi, A Mohamed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2011
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkersE-H Tan, C Goh, W T Lim, et al.
Asia-Pacific Journal of Clinical Oncology|December 15, 2021
Efficacy, toxicity, and quality-of-life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single-arm phase 2 trial from AsiaJanice S H Tan, Jonathan Y H Teh, Laura L Y Tan, et al.
Cancer Biology & Medicine|May 24, 2019
68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomyJanice S H Tan, Charles X Y Goh, Yen Sin Koh, et al.
The Pharmacogenomics Journal|May 28, 2014
Pharmacogenomic diversity in Singaporean populations and EuropeansL R Brunham, S L Chan, R Li, et al.
Oral Oncology|December 6, 2023
Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinomaJialing Neo, Pui Lam Yip, Enya H W Ong, et al.
Cancer Discovery|June 17, 2024
Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal CancersRaghuvaran Shanmugam, Prativa Majee, Wei Shi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
Pageof 25